ClinicalTrials.Veeva

Menu

Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Implicit Bias
Stigma, Social
Nurse's Role

Treatments

Other: ArtSpective

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06410287
R21DA055067 (U.S. NIH Grant/Contract)
HUM00248695

Details and patient eligibility

About

The goal of this pilot clinical trial is to evaluate the feasibility and limited effectiveness of a digital, arts-based educational intervention addressing nurse stigma towards perinatal substance use. The main questions it aims to answer are:

  • What is the the feasibility of delivering the training through an asynchronous, web-based platform?
  • What is the limited effectiveness of the program on nurse stigma towards perinatal substance use?

Participants will access and complete the training, including completion of a perinatal substance use stigma scale at baseline, immediately post, and 1-2 months month later. Participants will also be invited to participate in an interview.

Researchers will compare the intervention and control groups to see if the training reduces nurse stigma towards perinatal substance use.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • Licensed as a registered nurse
  • Works at least part time
  • Works on a labor, postpartum, nursery, neonatal intensive care, or pediatric unit in one of the participating hospitals

Exclusion criteria

  • Works as per diem or agency nurse
  • Not employed by a participating hospital
  • Not a perinatal/pediatric nurse

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Site 1
Experimental group
Description:
Participants from the hospital randomized to the experimental group will be first to receive an invitation to complete the web-based educational program. The program will be open for one month. Thirty days after a participant completes the program, they will be sent a link to a follow up survey (web-based). At 60 days, participants who completed the program and the first follow up survey will be randomized to complete a second follow up survey or participate in a 1:1 interview.
Treatment:
Other: ArtSpective
Site 2
Other group
Description:
Participants from the hospital randomized to the control setting will receive an invitation to complete a survey that collects baseline data for the outcome (stigma toward perinatal substance use) and demographic information. After thirty days, participants will be invited to complete the web-based educational program. Thirty days after completion, they will receive a link to a web-based follow up survey.
Treatment:
Other: ArtSpective

Trial contacts and locations

2

Loading...

Central trial contact

Clayton Shuman, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems